Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
4.210
-0.270 (-6.03%)
At close: Apr 24, 2024, 4:00 PM
4.350
+0.140 (3.33%)
After-hours: Apr 24, 2024, 4:56 PM EDT

Autolus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
7601,1201733784685941,159--
Market Cap Growth
-547.12%-54.25%-19.06%-21.26%-48.75%---
Enterprise Value
7441,104-59136368409969-102-28
PE Ratio
-5.38-5.38-1.16-2.66-3.29-4.79-25.89--
PS Ratio
447.65659.8927.23162.43272.63204.18823.43--
PB Ratio
6.8210.050.581.212.232.335.65--
P/FCF Ratio
-7.16-7.16-1.41-2.99-3.53-4.96-28.50--
P/OCF Ratio
-7.70-7.70-1.54-3.21-3.97-5.85-36.74--
EV/Sales Ratio
437.95650.19-9.3558.28214.36140.49688.89-60.44-23.00
EV/EBITDA Ratio
-7.23-7.230.46-1.05-2.29-3.04-19.264.572.01
EV/EBIT Ratio
-6.76-6.760.43-0.96-2.21-2.94-18.634.381.95
EV/FCF Ratio
-7.05-7.050.48-1.07-2.78-3.41-23.845.322.38
Debt / Equity Ratio
2.012.010.500.220.260.10--0.01
Debt / EBITDA Ratio
-1.47-1.47-1.17-0.53-0.34-0.20---0.01
Debt / FCF Ratio
-1.43-1.43-1.22-0.54-0.41-0.22---0.02
Quick Ratio
5.375.378.2610.884.588.4611.6221.2110.26
Current Ratio
6.156.159.1812.155.869.9811.6221.2111.31
Asset Turnover
0.000.000.020.010.010.010.010.02-
Interest Coverage
-3.62-3.62-15.68-127.54-----
Return on Equity (ROE)
-105.70%-105.70%-63.00%-49.80%-57.20%-47.60%-28.10%-27.30%-
Return on Assets (ROA)
-49.30%-49.30%-41.60%-41.10%-45.10%-40.30%-26.70%-26.00%-
Return on Capital (ROIC)
-53.59%-53.59%-31.95%-36.99%-63.64%-51.97%-28.05%-20.59%-46.56%
Earnings Yield
-27.41%-18.60%-85.96%-37.55%-30.39%-20.86%-3.86%--
FCF Yield
-20.60%-13.97%-71.12%-33.48%-28.33%-20.18%-3.51%--
Buyback Yield / Dilution
-83.11%-83.11%-31.78%-39.81%-19.72%-36.47%-128.95%-38.76%-
Total Shareholder Return
-83.11%-83.11%-31.78%-39.81%-19.72%-36.47%-128.95%-38.76%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).